More than 100 countries are pushing for a temporary waiver of IP rules to boost vaccine access for developing nations. Why hasn’t it been approved? As India grapples with a devastating Covid wave that has overwhelmed its hospitals, offers of aid, including from Australia, have… Read More »India wants access to cheap copies of Covid vaccines. So why is Australia holding out?
Health secretary says greater supplies of vaccine will help safeguard progress in tackling coronavirus Coronavirus – latest updates See all our coronavirus coverage The UK has ordered a further 60m doses of the Pfizer/BioNTech Covid vaccine in an effort to ensure that booster jabs can… Read More »UK orders 60m more doses of Pfizer Covid vaccine for booster jabs
As Valneva recruits volunteers for final stage trials of its vaccine, here is the current state of play in Britain Coronavirus – latest updates See all our coronavirus coverage Vaccines to protect against the coronavirus were designed, tested and manufactured in record time, and several… Read More »What Covid vaccines does the UK have and which are in the works?
Dr Mohga Kamal-Yanni says world leaders must stop putting big pharma’s profits before people’s lives. Sue Hoar wonders why more is not being done to help Covid patients in India The shortfall in Covid vaccine doses going to the Covax vaccine-sharing scheme is deeply worrying,… Read More »In the fight against Covid, have we been inoculated against compassion? | Letters
This week’s lacklustre results will strengthen boss Emma Walmsley’s case for reform – but also inspire her critics When the American hedge fund Elliott Management took a sizeable stake in GlaxoSmithKline this month, the drugmaker’s shares jumped 5% on speculation of a possible shake-up at… Read More »GlaxoSmithKline faces dose of strong medicine from US investor
Pharmaceutical companies insist secrecy is the only way. But what if they were obliged to share recipes and supply chains? Biolyse is a small pharmaceutical manufacturer in Canada with a simple proposition: provide a recipe for a coronavirus vaccine, and it will produce 20m doses… Read More »The world is desperate for more Covid vaccines – patents shouldn’t get in the way | Stephen Buranyi
Commission move causes concern about bringing case against key supplier of Covid vaccines Coronavirus – latest updates See all our coronavirus coverage EU capitals have been asked by the European commission to back legal action against AstraZeneca by the end of the week over an… Read More »EU asks states to back legal action against AstraZeneca
Pfizer boss flags likelihood that extra jabs will be required – raising prospect of increased global demand Covid booster shot could be needed after nine to 12 months, White House says Experts say suggestions that a third dose of Pfizer may be needed within 12… Read More »Covid booster shot warning ‘underlines urgent need for Australia to make mRNA vaccines’
Analysis: buying new and existing technologies ensured alternatives if a vaccine failed or had supply issues Coronavirus – latest updates See all our coronavirus coverage The government has said the decision by Johnson & Johnson to delay the supply of its Covid vaccine to Europe,… Read More »UK strategy of backing several Covid vaccines seems to be paying off
Company has said it is postponing deployment in Europe following concerns about blood clots in US Coronavirus – latest updates See all our coronavirus coverage The European commission is seeking “urgent clarification” from Johnson & Johnson after the company’s “completely unexpected” announcement that it has… Read More »EU seeking ‘urgent clarification’ on Johnson & Johnson Covid vaccine delay
Fear of third wave and new variants as sub-Saharan vaccine distribution is dogged by supply disruption Coronavirus – latest updates See all our coronavirus coverage Millions of healthcare workers in sub-Saharan Africa continue to risk their lives to fight Covid-19 as authorities across the continent… Read More »African health workers left without Covid jabs as paltry supplies dwindle
Woman in her 40s in Western Australia reported to be in hospital in a stable condition after developing clot Health authorities have concluded a second case of a rare blood clot syndrome in Australia “is likely” linked to the AstraZeneca vaccine. The case occurred in… Read More »Australia reports second blood clot case ‘likely’ linked to AstraZeneca Covid vaccine
Pharmaceutical firms warn of delays to items such as the large bags in which vaccine cells are grown Coronavirus – latest updates See all our coronavirus coverage Vaccine-makers around the world face shortages of vital components including large plastic growbags, according to the head of… Read More »Global Covid vaccine rollout threatened by shortage of vital components
EMA says four serious cases reported, one fatal, and also expands inquiry into AstraZeneca vaccine Coronavirus – latest updates See all our coronavirus coverage The EU’s drug regulator is reviewing reports of rare blood clots in four people who received Johnson & Johnson’s Covid-19 vaccine… Read More »EU agency examines reports of blood clots with J&J Covid vaccine
Experts say the development of blood clots after getting the jab is still an ‘exceedingly rare’ side effect. So what triggered the government’s change in position? Australia’s vaccine rollout is facing a major shake-up after the federal government heeded the advice of its independent health… Read More »What does Australia’s new advice on the AstraZeneca Covid vaccine mean and what is the risk?
Prof David Spiegelhalter says advantages of vaccinating young people far outweigh risks Coronavirus – latest updates See all our coronavirus coverage People in their 20s should continue to get vaccinated against Covid despite the very rare cases of blood clotting linked to the Oxford/AstraZeneca vaccine… Read More »Coronavirus: UK expert urges people in 20s to keep getting vaccine
Downing Street will not confirm or deny report that more than 700,000 Covid jabs were sent after EU blocked export Coronavirus – latest updates See all our coronavirus coverage British ministers and officials did not deny that more than 700,000 shots of the AstraZeneca vaccine… Read More »UK ministers silent on AstraZeneca vaccine shipment to Australia
England’s deputy chief medical officer says delay would be precaution against rare side-effect of blood clots Coronavirus – latest UK updates See all our coronavirus coverage People under 30 have been told there may be a “small delay” to when they will receive a coronavirus… Read More »Under-30s may have ‘small delay’ in getting Covid jab, says Jonathan Van-Tam
People urged to keep getting Covid vaccine, with EMA and MHRA expected to give updates on investigation into rare blood clots Coronavirus – latest updates See all our coronavirus coverage Government advisers say concerns over the Oxford/AstraZeneca jab are being taken “very seriously” and “very… Read More »AstraZeneca jab: UK government says concerns being investigated thoroughly
Despite scientific advice to continue getting the jab, answers about fatal blood clots are urgently needed Coronavirus – latest updates See all our coronavirus coverage Vaccines have side-effects, as do all medicines. Most often, jabs cause sore arms, a headache or a bit of nausea… Read More »AstraZeneca Covid vaccine: weighing up the risks and rewards
Medicines Healthcare products Regulatory Authority was considering restricting vaccine amid concerns over rare blood clots Coronavirus – latest updates See all our coronavirus coverage The UK’s medicines regulatory body has said that no decision has been made on any regulatory action relating to the Oxford/AstraZeneca… Read More »Medicines watchdog says no decision made AstraZeneca jab for under-30s
Experts urge public to go for inoculations as benefits far outweigh potential complications Coronavirus – latest updates See all our coronavirus coverage Health officials are becoming increasingly worried that younger people will reject Covid jabs as concerns about the AstraZeneca vaccine continue to grow. A… Read More »Blood clot cases ‘could dent faith of young women in AstraZeneca’
Half of UK adults have had a first jab, and future supplies of millions of doses look assured Coronavirus – latest updates See all our coronavirus coverage Two very different jabs have been responsible for inoculating Britain’s strikingly high number of vaccine recipients – with… Read More »Two new vaccines on the way – with more to follow this year
Findings based on two doses three weeks apart are first to show shot remains effective for many months Coronavirus – latest updates See all our coronavirus coverage The coronavirus vaccine developed by Pfizer and its German partner BioNTech protects against symptomatic Covid for up to… Read More »Pfizer vaccine has 91% efficacy for up to six months, trial shows
Deal is intended to boost domestic supply amid fears potential export bans could hit vaccine shipments Coronavirus – latest updates See all our coronavirus coverage The UK will produce up to 60m doses of a Covid-19 vaccine under a new deal struck to boost domestic… Read More »UK to make up to 60m doses of Novavax Covid vaccine under GSK deal
The company has struggled, like its rivals, to keep up with demand. But it has achieved great things at low prices AstraZeneca is one of the shining stars of the pandemic. Not only did it produce a vaccine where other big players failed, the UK-Swedish… Read More »Safe, stable, sold at cost: AstraZeneca’s vaccine deserves celebration, not scorn
Serum Institute boss Adar Poonawalla has rented a Mayfair mansion for £50,000 a week Coronavirus – latest updates See all our coronavirus coverage The AstraZeneca vaccine has made Prof Sarah Gilbert – who led the Oxford team that created it – one of the UK’s… Read More »‘Vaccine prince’: the Indian billionaire set to make Covid jabs for the UK
Worldwide focus on Covid-19 means a ‘minor issue’ is getting media attention, experts say Australia’s Covid vaccine rollout would be ‘dire’ without local AstraZeneca production, health chief says Australia’s drug regulator, the Therapeutic Goods Administration, has dismissed questions raised about “outdated information” in AstraZeneca vaccine… Read More »AstraZeneca vaccine: Australia’s drug regulator dismisses questions raised in US about outdated data
Bloc expected to assess countries’ Covid vaccination coverage and record in facilitating exports to EU Coronavirus – latest updates See all our coronavirus coverage The EU is expected to take into account the level of vaccination coverage in a country and its record in facilitating… Read More »EU to widen criteria for possible Covid vaccine export bans
Vaccinating the world is the only way out of Covid, but a mixture of nationalism and protectionism is blocking the exit Covid-19 has proved to be the greatest humanitarian and economic disaster of the century. A reported 2.7 million people have already died from the… Read More »The Guardian view on pandemic politics: we need cooperation, not confrontation | Editorial
PM stresses need to work with EU and says surge in infections is likely to ‘wash up on our shores’ Coronavirus – latest updates See all our coronavirus coverage Boris Johnson has urged international cooperation over vaccines, saying a third wave of coronavirus elsewhere in… Read More »Boris Johnson: vaccine cooperation vital to help combat third Covid wave
After a week of bans, U-turns and warnings of supply shortfalls, public confidence in vaccination has been dented. Can Britain get back on the fast track out of lockdown? Coronavirus – latest updates See all our coronavirus coverage For Stacey Harris, the hardest part of… Read More »Vaccine wars: the week that rocked the UK’s Covid jab rollout
Three Scandinavian countries reserve judgment one day after EMA says shot is safe and effective Coronavirus – latest updates See all our coronavirus coverage France has said only people aged 55 and over should receive the AstraZeneca Covid-19 vaccine, and three Scandinavian countries have reserved… Read More »France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously
Three Scandinavian countries reserve judgment one day after EMA says shot is safe and effective Coronavirus – latest updates See all our coronavirus coverage France has said only people aged 55 and over should receive the AstraZeneca Covid-19 vaccine, and three Scandinavian countries have reserved… Read More »France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously
Pooling the European Covid vaccine effort was a noble idea. In practice, it has been a disaster In the race between vaccines and new Covid-19 variants, I am on the losing team. There is a simple reason for this, and it is because I live… Read More »The EU’s AstraZeneca vaccine stance will cost lives, here in Spain and all over Europe
Pooling the European Covid vaccine effort was a noble idea. In practice, it has been a disaster In the race between vaccines and new Covid-19 variants, I am on the losing team. There is a simple reason for this, and it is because I live… Read More »The EU’s AstraZeneca vaccine stance will cost lives, here in Spain and all over Europe
The UK’s chief scientific adviser loves good food, enjoys a Scandi drama – and has been called ‘the richest civil servant in history’ Sir Patrick Vallance spent his 60th birthday at a podium in Downing Street, flanking Boris Johnson. Whatever plans he had were scrapped.… Read More »Patrick Vallance: the adviser who spoke scientific truth to power
The UK’s chief scientific adviser loves good food, enjoys a Scandi drama – and has been called ‘the richest civil servant in history’ Sir Patrick Vallance spent his 60th birthday at a podium in Downing Street, flanking Boris Johnson. Whatever plans he had were scrapped.… Read More »Patrick Vallance: the adviser who spoke scientific truth to power
The newness of some of the technology and gaps in global preparedness have led to bottlenecks Coronavirus – latest updates See all our coronavirus coverage When the first Covid-19 vaccines were approved in the UK and elsewhere three months ago, many thought the end of… Read More »How are Covid vaccines produced and why have there been delays?
The newness of some of the technology and gaps in global preparedness have led to bottlenecks Coronavirus – latest updates See all our coronavirus coverage When the first Covid-19 vaccines were approved in the UK and elsewhere three months ago, many thought the end of… Read More »How are Covid vaccines produced and why have there been delays?
EMA says benefits outweigh risks but it is continuing to study possible link with very rare blood clotting disorder Coronavirus – latest updates See all our coronavirus coverage Italy, France, Germany and several other countries will resume administering AstraZeneca jabs from Friday after Europe’s medicines… Read More »European countries to resume AstraZeneca jabs after safety backing
EMA says benefits outweigh risks but it is continuing to study possible link with very rare blood clotting disorder Coronavirus – latest updates See all our coronavirus coverage Italy, France, Germany and several other countries will resume administering AstraZeneca jabs from Friday after Europe’s medicines… Read More »European countries to resume AstraZeneca jabs after safety backing
Bloc hopes to resolve row as it emerges big member states back threat to halt jab exports Coronavirus – latest updates See all our coronavirus coverage The EU is to send a formal letter to AstraZeneca in an attempt to resolve its dispute over vaccine… Read More »EU to send formal letter to AstraZeneca in Covid vaccine dispute
Bloc hopes to resolve row as it emerges big member states back threat to halt jab exports Coronavirus – latest updates See all our coronavirus coverage The EU is to send a formal letter to AstraZeneca in an attempt to resolve its dispute over vaccine… Read More »EU to send formal letter to AstraZeneca in Covid vaccine dispute
European agency seeks to allay blood clot fears as Germany, France and Italy temporarily suspend use Coronavirus – latest updates See all our coronavirus coverage Europe’s medicines regulator has moved to stifle spiralling concern about the Oxford/AstraZeneca vaccine, saying the shot’s benefits outweigh the risks… Read More »Benefits of Oxford/AstraZeneca vaccine outweigh any risk, says EMA
Parents whose only hope was finding foreign sponsorship or a clinical trial are now looking for homegrown breakthroughs For three years, Vidya tried to find the cause of her son’s recurrent fevers and low cognitive development. When she found out, she was devastated. Vineeth, 10,… Read More »What price a child’s life? India’s quest to make rare disease drugs affordable
Deployment of Oxford vaccine temporarily deferred after latest reports from Norway Coronavirus – latest updates See all our coronavirus coverage Ireland is suspending use of the Oxford/AstraZeneca vaccine against Covid as a precautionary measure following further reports of blood clots in people who have received… Read More »Ireland suspends AstraZeneca Covid vaccine over blood clot concerns
Health agency suspends use of Covid jab but says no conclusive link has been established Coronavirus – latest updates See all our coronavirus coverage Denmark’s national health agency has said it is temporarily suspending inoculations with the AstraZeneca vaccine after blood clots formed in several… Read More »Denmark pauses use of AstraZeneca vaccine to investigate blood clot reports
The scientific community are rising to the challenge, undertaking an unprecedented global health programme Pascal Soriot is the chief executive officer of AstraZeneca Coronavirus – latest updates See all our coronavirus coverage Covid-19 is a virus that knows no boundaries and has inflicted terrible suffering… Read More »At AstraZeneca, we know that until everyone is safe from Covid, no one is safe | Pascal Soriot
Özlem Türeci credits firm’s more than 50% female workforce for speed at which first viable jab created The co-founder and chief medical officer of BioNTech has credited its speed at producing a viable vaccine to the fact its workforce is more than 50% female. Speaking… Read More »BioNTech co-founder says gender equality made vaccine possible
Zolgensma, which costs £1.79m for one-off treatment, will be available in England this year for the first time The world’s most expensive drug, which treats babies and young children with a rare and often fatal degenerative disorder, will be available this year for the first… Read More »NHS to use world’s most expensive drug to treat spinal muscular atrophy
The companies in line for the biggest gains – and the shareholders who have already made fortunes Coronavirus – latest updates See all our coronavirus coverage The arrival of Covid-19 vaccines promises a return to more normal life – and has created a global market… Read More »From Pfizer to Moderna: who’s making billions from Covid vaccines?
Row continues between EU and drug firm after shortfall in vaccine deliveries to bloc Coronavirus – latest updates See all our coronavirus coverage Italy has blocked the export of 250,000 doses of the Oxford/AstraZeneca vaccine to Australia in an escalation of a row with the… Read More »Italy blocks export of 250,000 AstraZeneca vaccine doses to Australia
Joy and relief from campaigners as chancellor’s budget extends support that had been due to run out in 2023 Analysis: Sunak digs in for battle against financial cost of Covid Budget 2021: key points at a glance Budget 2021 live: Sunak to freeze income tax… Read More »Thalidomide scandal: Sunak pledges lifetime support for survivors
Healthcare workers with obesity found to produce only about half the antibodies healthy people do Coronavirus – latest updates See all our coronavirus coverage The Pfizer/BioNTech vaccine may be less effective in people with obesity, data suggests. Italian researchers have discovered that healthcare workers with… Read More »Pfizer vaccine may be less effective in people with obesity, says study
About 3,300 women a year may benefit from decision to approve ribociclib Women with incurable advanced breast cancer will be able to get a drug from the NHS that can potentially extend their life by almost eight months, under new guidance. The National Institute for… Read More »Life-extending drug for incurable breast cancer approved for NHS use
Former prime minister tells the Guardian the world must be better prepared for the next pandemic World leaders could have cut the length of the Covid outbreak by three months if they had collaborated on vaccines, testing and drugs, Tony Blair has claimed as he… Read More »Blair says collaboration on Covid could have cut three months off crisis
UCSF’s interactive data platform allows users to drill down into 150 social determinants of health variables. This data, layered with EHR data, can give researchers and clinicians invaluable insights into the nexus of social factors and health.
Updated versions of vaccine are being developed in case variants evade immunity provided by current shots Coronavirus – latest updates See all our coronavirus coverage Clinical trials of vaccines against new variants of coronavirus will start in the summer to ensure updated boosters are available… Read More »Vaccine clinical trials for Covid variants to start in summer, MPs told
Factors at play include high uptake plus stockpiling for second doses, but Matt Hancock promises ‘bumper weeks in March’ Coronavirus – latest updates See all our coronavirus coverage The number of Covid vaccines administered in the UK has fallen by over a third in the… Read More »Number of UK Covid vaccinations falls by a third as vaccine supply dips
Pressure mounts for patent waivers to allow poorer countries to develop their own manufacturing capacity to boost availability The domination of global medicine by major pharmaceutical companies needs to be confronted to provide fairer access to vaccines, a leading South African official has said. The… Read More »South Africa leads backlash against big pharma over access to Covid vaccines
A huge effort has helped the UK provide 14m first doses of Covid vaccines in about two months Coronavirus – latest updates See all our coronavirus coverage In St Albans, GPs took over a former nightclub to provide Covid vaccinations every 20 seconds; in Carnforth,… Read More »‘It shows what we’re capable of’: the NHS’s vaccine triumph
Anglo-Swedish pharmaceutical firm’s profits rise to $7.4bn as main business ‘remains strong’ Coronavirus – latest updates See all our coronavirus coverage AstraZeneca has said it could take between six and nine months to produce Covid-19 vaccines that are effective against new variants of the coronavirus.… Read More »AstraZeneca says vaccine against new Covid variants may take six months
From doubts about safety in older people to questions about variants, scientists have faced a battle to convince the public and regulators Coronavirus – latest updates See all our coronavirus coverage The Oxford University/AstraZeneca vaccine against Covid has barely been out of the news from… Read More »A series of knocks: Oxford/AstraZeneca’s bumpy road to Covid vaccine confidence
Small-scale trial of vaccine’s efficacy shows it offers very little protection against mild to moderate infection Coronavirus – latest updates See all our coronavirus coverage The Oxford/AstraZeneca vaccine offers as little as 10% protection against the Covid variant first seen in South Africa, researchers have… Read More »Oxford Covid vaccine 10% effective against South African variant, study suggests
While CBD has been approved for over-the-counter sale, there are regulatory hurdles to clear before it actually appears in pharmacies “You can have as much whiskey as you like, but there’s no whiskey available,” says Prof Iain McGregor, psychopharmacologist and academic director of the Lambert… Read More »CBD will go on sale in Australia, but first manufacturers will have to prove it works
Scientists behind AstraZeneca vaccine say it has similar efficacy against variant as against original Covid Coronavirus – latest updates See all our coronavirus coverage The Oxford/AstraZeneca coronavirus vaccine is just as effective at fighting the UK variant as it is the original virus, new research… Read More »Oxford Covid vaccine just as effective against Kent variant, trials suggest
Government to work with German firm CureVac on tackling potential mutations Coronavirus – latest updates See all our coronavirus coverage The UK government has signed a deal for at least 50m doses of vaccines that could combat new variants of coronavirus, and is to work… Read More »UK orders 50m doses of Covid vaccines in fight against variants
Companies hope to have next generation of vaccines against emerging variants by next year GlaxoSmithKline and Germany’s CureVac have reached a €150m (£132m) agreement to develop a next generation of Covid-19 vaccines targeting new emerging variants in the pandemic. The two companies said they they… Read More »GSK and CureVac sign £132m deal to develop multi-variant Covid vaccine
One jab could also offer protection of up to 76% for up to 12 weeks, a new study shows Coronavirus – latest updates See all our coronavirus coverage A single dose of the Oxford/AstraZeneca vaccine may reduce transmission by 67% and give protection of 76%… Read More »Single dose of AstraZeneca vaccine could cut transmission by 67%
Analysis: death rates in intensive care are falling as doctors identify more ways to help those with the disease Coronavirus – latest updates See all our coronavirus coverage Vaccines may have been described as the great escape route from the Covid pandemic – but treatments,… Read More »Even with vaccines, we still need treatments for Covid. So what works?
Shots: The Health Canada has granted a NOC which is based on clinical evidence for Remsima/CT-P13 SC vs CT-P13 IV up to 1year in patients with RA. The results demonstrated that switching patients from Remsima IV to its SC formulation @30wks. is comparable to maintaining… Read More »Celltrion Receives Health Canada’s Approval for Remsima SC (biosimilar, infliximab) for Rheumatoid Arthritis
Commission plans to rush through regulations that ‘ensure Northern Ireland protocol remains unaffected’ Coronavirus – latest updates See all our coronavirus coverage Explainer: what is article 16 of the Northern Ireland protocol? Brussels will publish a revised regulation to potentially block vaccine exports out of… Read More »EU to publish revised rules after Covid vaccine border fiasco
Pre-ordering of Janssen and Novavax means Britain has procured 247m successfully trialled jabs Coronavirus – latest updates See all our coronavirus coverage Britain has cemented its status as one of the world’s leading buyers of effective Covid vaccines after two more pharmaceutical companies reported positive… Read More »UK vaccine strategy ‘paying off’ as latest trials boost stockpiles
The shortfall in supply has put the EU and the UK at loggerheads, but ethical principles could reveal a solution In normal times, a row between the EU, the UK and a private company over the timely delivery of a contract would be of interest… Read More »What can moral philosophy tell us about the Covid ‘vaccine nationalism’ row? | Alexis Papazoglou
Everything you need to know about the trial results for a new coronavirus vaccine Coronavirus – latest updates See all our coronavirus coverage In an interim analysis of a phase 3 clinical trial conducted in the UK, the vaccine has been shown to be nearly… Read More »How effective is the Novavax Covid vaccine and will it work against variants?
Everything you need to know about the trial results for a new coronavirus vaccine Coronavirus – latest updates See all our coronavirus coverage In an interim analysis of a phase 3 clinical trial conducted in the UK, the vaccine has been shown to be nearly… Read More »How effective is the Novavax Covid vaccine and will it work against variants?
UK vaccines taskforce has bought 60m doses after study found ‘spectacular results’ Coronavirus – latest updates See all our coronavirus coverage Another vaccine against Covid, trialled in the UK and bought by the government, has been shown to be nearly 90% effective and work against… Read More »Novavax Covid vaccine shown to be nearly 90% effective in UK trial
Slowness to sign up to and approve the vaccine may have caused delays, but Brussels feels the company is being less than cooperative Coronavirus – latest updates See all our coronavirus coverage Last year AstraZeneca was heralded for its pioneering vaccine discovery. Yet today the… Read More »The EU’s vaccine bust-up with AstraZeneca is of its own making | Leo Cendrowicz
Commission president says firms must deliver on orders after AstraZeneca warns of shortfall Coronavirus – latest updates See all our coronavirus coverage The EU “means business”, Ursula von der Leyen has said, as the bloc doubled down on plans for tighter monitoring of vaccine exports… Read More »EU means business over Covid vaccine exports, says Von der Leyen
British Society for Immunology calls for a robust programme monitoring the body’s immune response Experts have called for greater clarity on the monitoring in place to assess the 12-week dosing interval for Covid-19 vaccines, as the row over delayed second doses continues. The UK’s coronavirus… Read More »Vaccine experts call for clarity on UK’s 12-week Covid jab interval
British Society for Immunology calls for a robust programme monitoring the body’s immune response Experts have called for greater clarity on the monitoring in place to assess the 12-week dosing interval for Covid-19 vaccines, as the row over delayed second doses continues. The UK’s coronavirus… Read More »Vaccine experts call for clarity on UK’s 12-week Covid jab interval
Exactly a year after his first story about coronavirus, our science editor received the Pfizer injection last week. Here he reflects on a remarkable scientific achievement Coronavirus – latest updates See all our coronavirus coverage I marked a grim anniversary in an unexpected manner last… Read More »I’ve had my first vaccine jab. It gives me hope of liberation… but not yet
Medics told they risk undermining public confidence by querying policy of three-month gap between doses Coronavirus – latest updates See all our coronavirus coverage Leading vaccine experts have backed the government’s decision to delay the second dose for up to three months, after doctors warned… Read More »Vaccine experts defend UK decision to delay second Pfizer Covid jab
Nations outbidding each other creates an ‘immoral race towards the abyss’ Coronavirus – latest updates See all our coronavirus coverage Pharmaceutical companies should do more to transfer vaccine technology to prevent the poorest countries falling behind in the distribution of Covid-19 vaccines, according to an… Read More »World’s poor need action, not Covid ‘vaccine nationalism’, say experts
Scientists start work on steps needed for potential rapid development of a modified vaccine, AstraZeneca says Coronavirus – latest updates See all our coronavirus coverage The UK medicines regulator is in discussions with coronavirus vaccine manufacturers about “potential modifications” that may be needed to ensure… Read More »MHRA and vaccine makers in talks over new Covid variants
Exclusive: ‘pool’ to share Covid-19 information has received no contributions since May 2020 Coronavirus – latest updates See all our coronavirus coverage A World Health Organization program for pharmaceutical companies to voluntarily share Covid-19 related knowledge, treatments and technology so they can be more widely… Read More »WHO platform for pharmaceutical firms unused since pandemic began
Surge in infections dampens optimism over country’s advanced immunisation programme Coronavirus – latest updates See all our coronavirus coverage Israel’s coronavirus tsar has warned that a single dose of the Pfizer/BioNtech vaccine may be providing less protection than originally hoped, as the country reported a… Read More »Single Covid vaccine dose in Israel ‘less effective than we hoped’
Evidence growing that spacing doses of Pfizer vaccine improves effectiveness Coronavirus – latest updates See all our coronavirus coverage Second shots of coronavirus vaccine could be delayed even further amid growing evidence that spacing out the doses improves their effectiveness. The NHS vaccination programme aims… Read More »Second shots of Covid vaccine could be delayed further in England
Australia has secured 54m doses of the vaccine some experts say is inferior to Pfizer’s mRNA vaccine, which Australia has bought just 10m doses of Covid hotspots Victoria; NSW hotspots; Queensland hotspots NSW and Sydney trend map: where cases are rising or falling Follow the… Read More »Australia’s chief medical officer defends AstraZeneca’s Covid vaccine amid efficacy concerns
Bloc agrees deal for a further 300m doses as hopes are raised for speedier rate of inoculations Coronavirus – latest updates See all our coronavirus coverage EU leaders are to hold a pandemic video summit on 21 January after the bloc said it had reached… Read More »EU plans video summit after doubling supply of Pfizer Covid vaccine
Britain’s third jab to receive clearance for public use will not be available until the spring Coronavirus – latest updates See all our coronavirus coverage The Moderna coronavirus vaccine has been approved for use in the UK. The jab is the third to be given… Read More »Moderna Covid vaccine approved for use by UK medicines regulator
Moderna jab won’t be available in Britain until April but fourth vaccine may soon come online Coronavirus – latest updates See all our coronavirus coverage A third Covid vaccine is likely to be approved for use in Britain next week but it will not be… Read More »Third Covid vaccine set for UK approval next week but arrival delayed by Brexit
The dire state of UK manufacturing has left us dependent on other nations. We may soon find out why some call this a ‘national security risk’ Everything now hinges on a vaccine: how many more Britons die, whether the NHS finally breaks, how long the… Read More »Britain could be mass-producing its Covid shot. Shame we junked our industrial base | Aditya Chakrabortty
Nadhim Zahawi says ‘absolute focus’ is to get 13.9 million people inoculated by mid-February Coronavirus – latest updates See all our coronavirus coverage The UK vaccine minister, Nadhim Zahawi, has pledged a “massive uplift” in the number of coronavirus vaccinations carried out this week as… Read More »UK vaccine minister vows ‘massive uplift’ in number of jabs this week
The insurer will pay $95 per share in cash to acquire Magellan Health, a company providing an array of services, including pharmacy benefit management and behavioral health and employee assistance program services. The companies aim to develop a behavioral health platform.
Move to postpone second jab by up to 12 weeks is not supported by scientific evidence, experts find Coronavirus – latest updates See all our coronavirus coverage There is no scientific evidence for a delay of more than six weeks in administering the second dose… Read More »No data to support UK delay of vaccines’ second dose, says WHO
The Lincoln Health Network is excited to announce our 2nd Medical Writing Landscape Advancement Summit, March 3-4, 2021. Join us virtually, on the LHN virtual event platform to improve your medical writing strategies by understanding evolving regulatory protocols and submission guidelines, and learn how to… Read More »Medical Writing Landscape Advancement Summit | Virtual
US experts warn against plan to give different second jab if supplies run low Coronavirus – latest updates See all our coronavirus coverage The UK is setting the pace around the world in the approval and use of Covid vaccines but, while other countries watch… Read More »Analysis: is it wise for England to mix and match Covid vaccines?
With jab to be administered to public for first time, we look at key questions about its rollout Coronavirus – latest updates See all our coronavirus coverage The biggest vaccination programme in the UK’s history will receive a major boost on Monday, with the first… Read More »How is the Oxford Covid vaccine being deployed in England?
Fall or rise in coronavirus cases will not initially be a good measure of efficacy, say scientists devising ways to audit progress Why is Britain delaying second doses of vaccine? Coronavirus – latest updates See all our coronavirus coverage People in Britain are set to… Read More »The Oxford Covid jab is delivered this week. But when will vaccines bring results?
We look at how the introduction of a new vaccine in the fight against Covid will work Coronavirus – latest updates See all our coronavirus coverage The Oxford/AstraZeneca vaccine is central to the government’s plans for ending social distancing in the UK and returning to… Read More »What difference will Oxford/AstraZeneca vaccine make in UK?
The effectiveness of delaying the second dose of Covid vaccines must be carefully monitored, argues Dr Grizelda George, while Jan Mortimer and Jenny van Tinteren fear the move will increase distrust and uncertainty The manufacturer of the Pfizer/BioNTech vaccine has said its efficacy has only… Read More »Change in vaccine policy is a high-stakes gamble | Letters
Analysis: regulator surprises by approving 12-week gap between first and second shots of vaccine as well as Pfizer/BioNTech shot Coronavirus – latest updates See all our coronavirus coverage It’s a pragmatic solution to an incredibly urgent problem – how to immunise very large numbers of… Read More »Questions hang over UK’s rollout of Oxford/AstraZeneca jab
Shots: Myovant & Pfizer will jointly develop & commercialize ORGOVYX (relugolix) in advanced prostate cancer & if approved, relugolix combination tablet in women’s health in the US & Canada. Myovant will receive ~$4.2B including $650M upfront, $200M in regulatory milestones for FDA approvals for relugolix… Read More »Myovant Signs Agreement with Pfizer to Develop and Commercialize Relugolix in Oncology and Women’s Health
Many medics ‘frustrated’ about low priority given to frontline staff at high risk of infection Coronavirus – latest updates See all our coronavirus coverage Frontline NHS staff have been denied the Pfizer/BioNTech vaccine, leaving doctors alarmed and “scrabbling” to get immunised. A new survey reveals… Read More »NHS doctors ‘scrabbling’ to get vaccine amid alarm at Covid variant
Exclusive: antibody therapy could confer instant immunity against Covid-19 to at-risk groups See all our coronavirus coverage British scientists are trialling a new drug that could prevent someone who has been exposed to coronavirus from going on to develop the disease Covid-19, which experts say… Read More »UK scientists trial drug to prevent coronavirus infection leading to disease
Other firms better placed to supply antibody tests, argues case against health secretary Matt Hancock Coronavirus – latest updates See all our coronavirus coverage The government was operating an illegal “buy British” policy when it signed contracts with a small UK firm to supply Covid… Read More »Government ‘operated illegal buy British policy’ over Covid contracts
Pharmaceutical companies complain of breach of confidentiality after amount EU has agreed to pay for leading vaccines goes public Coronavirus – latest updates See all our coronavirus coverage A Belgian minister has inadvertently blown the lid off a sensitive and commercial secret – the price… Read More »Belgian minister tweets EU’s Covid vaccine price list to anger of manufacturers
Shots: Health Canada has authorized Hyrimoz on Nov 4, 2020 for marketing in Canada. Hyrimoz has been approved for use in all same indications as reference Humira, including rheumatology, gastroenterology and dermatology A patient support program will be available to patients treated with Hyrimoz providing… Read More »Sandoz to Launch Hyrimoz (biosimilar, adalimumab) in Canada
Trials reveal vaccine failed to produce a strong immune response in older people Coronavirus – latest updates See all our coronavirus coverage A coronavirus vaccine being developed by GlaxoSmithKline and its French partner, Sanofi, will be delayed until the end of next year after trials… Read More »GSK/Sanofi Covid vaccine delayed until end of next year
The challenge of delivering vaccines on this scale are hard, but are firmly within the world of logistics, engineering, and politics Coronavirus – latest updates See all our coronavirus coverage The UK has become the first country to approve one of the coronavirus vaccines that… Read More »Can the UK deliver on the Covid vaccine rollout? | Stephen Buranyi
Papers relating to Pfizer/BioNTech vaccine reportedly targeted in attack on European Medicines Agency German biotech firm BioNTech said on Wednesday that regulation documents related to the Covid-19 vaccine it has developed with Pfizer were “unlawfully accessed” after a cyber-attack on Europe’s medicines regulator. Earlier, the… Read More »Hackers accessed vaccine documents in cyber-attack on EMA
Medical director warns of great hurdles in largest vaccination campaign in UK history Coronavirus – latest updates See all our coronavirus coverage Batches of the Covid vaccine have begun to arrive in hospitals around the UK, ready for the first jabs on Tuesday in what… Read More »Covid vaccine arrives in UK hospitals ready for first jabs
Vaccine safety message ‘vitally important’, head of medicines regulator tells Andrew Marr Show Coronavirus – latest updates See all our coronavirus coverage Public health messaging that people can have faith in the safety of coronavirus vaccines is “vitally important”, the leader of the body that… Read More »Covid-19 vaccine ‘very safe and highly effective’, UK health chief says
We trace the extraordinary research effort, from the discovery of the virus’s structure to the start of inoculations this week Coronavirus – latest updates See all our coronavirus coverage In the early afternoon of 3 January this year, a small metal box was delivered to… Read More »The vaccine miracle: how scientists waged the battle against Covid-19
Shots: Abbott’s next-generation, sensor-based glucose monitoring technology, FreeStyle Libre 2, received Health Canada’s approval for adults & children with diabetes The system continuously measures glucose data every minute with customizable, optional real-time alarms to alert users when their glucose is high/low without scanning The technology… Read More »Abbott’s FreeStyle Libre 2 Receives Health Canada’s Approval for Adults and Children with Diabetes
Increase in women being diagnosed with depression partly behind rise in use An increase in women being diagnosed with depression is partly behind a significant rise in prescriptions of the antidepressant sertraline – sold under the brand name Zoloft – which is in the list… Read More »Zoloft enters list of 10 most commonly prescribed drugs in Australia
Trials will not reveal all the facts on prevention for each new drug – that process could last for years Coronavirus – latest updates See all our coronavirus coverage In a few days, researchers plan to solve a medical mystery that threatens to erupt into… Read More »Oxford controversy is the first shot in international battle over vaccine efficiency
Oxford/AstraZeneca planning new trial of lower-dose jab to see how well it works in older people Coronavirus – latest updates See all our coronavirus coverage Concerns around the efficacy of the Oxford University/AstraZeneca coronavirus jab in older people could lead to different age groups being… Read More »Different age groups may get different Covid vaccines, experts say
Pioneered by a Turkish-German couple, its significance exceeds its practical value The world took note when the German startup BioNTech announced its breakthrough in the development of a new type of vaccine to combat Covid-19. After testing tens of thousands of people, BioNTech’s vaccine has… Read More »BioNTech’s Covid vaccine is a triumph of innovation and immigration | Hans-Werner Sinn
The hunt for a coronavirus vaccine is showing promise but it is premature to say the end of the pandemic is nigh. Several rich countries have signed a ‘frenzy of deals’ that could prevent many poor nations from getting access to immunisation until at least 2024. Also, many drug… Read More »Will everyone in the world have access to a Covid vaccine? – video explainer
Do not demonise. To optimise the vaccine rollout, all of us must show respect to those who are unsure about inoculations Will Hanmer-Lloyd is a behavioural strategist The Covid-19 vaccines, which are up to 95% effective, have the potential to save millions of lives in… Read More »Here’s how to tackle the Covid-19 anti-vaxxers | Will Hanmer-Lloyd
Results from clinical trials have shown that the world has three apparently highly effective vaccines for Covid-19. With the race now on for regulatory approval, production and distribution, is the end of the pandemic within reach? After a gruelling year of successive waves of Covid-19… Read More »A vaccine revolution | podcast
Latest breakthrough comes as PM says he hopes most at-risk could be immunised by Easter Coronavirus – latest updates See all our coronavirus coverage The world is moving a step closer to ending the coronavirus pandemic, the scientist behind Britain’s first vaccine has declared, as… Read More »Vaccine results bring us a step closer to ending Covid, says Oxford scientist
Experts say Pfizer/BioNTech product faces more logistical challenges and obstacles Coronavirus – latest updates See all our coronavirus coverage The Oxford vaccine is likely to be the first Covid jab that large numbers of Britons receive, despite Pfizer’s candidate already being analysed by the medicines… Read More »Oxford/AstraZeneca vaccine ‘likely first to be widely used in UK’
Trial participants react to news that Oxford AstraZeneca Covid vaccine has up to 90% efficacy Coronavirus – latest updates See all our coronavirus coverage Dan McAteer describes his reaction more as a sense of relief than elation when his phone pinged on Monday morning with… Read More »‘It’s a great day’: Oxford coronavirus vaccine volunteers on trial data
Jab can be kept in fridge and is part of global initiative to distribute doses at limited cost Coronavirus – latest updates See all our coronavirus coverage The efficacy of the Oxford University/AstraZeneca vaccine opens the way for a cheap and more easily transportable vaccine… Read More »Oxford AstraZeneca results open up Covid vaccine to developing countries
Shots: The authorization is based on P-II BLAZE-1 study assessing the efficacy and safety of bamlanivimab (700/2800/7000 mg) alone or in combination with a second Ab vs PBO for the treatment of symptomatic COVID-19 in the outpatient setting Results: reduction in viral load & rates… Read More »Lilly’s Bamlanivimab (LY-CoV555) Receives Health Canada’s Interim Authorization as a Treatment for COVID-19
Plans for mass immunisation against Covid-19 are developing fast, but concerns must be addressed In the 1960s, academics studying rumours drew inspiration from epidemiology. They noted how such stories spread through communities, “infecting” some individuals while others seemed immune, and how more resistant populations could… Read More »The Guardian view on coronavirus and vaccine scepticism: time to act | Editorial
No one knew whether mRNA technology would work against this virus – but it does. It’s an extraordinary moment for science Coronavirus – latest updates See all our coronavirus coverage The past few months have brought a number of scientific terms to public attention. We’ve… Read More »Do mRNA vaccines for Covid signal a new era in disease prevention? | Adam Finn
Scientists say jab could be used to protect those who cannot be given vaccines Coronavirus – latest updates See all our coronavirus coverage Major trials will begin this weekend of an antibody cocktail that scientists hope will protect people against Covid-19 and could be swiftly… Read More »Trials to begin in UK for Covid antibody cocktail drug treatment
Request will be made at WTO meeting in order to allow mass production of treatments Coronavirus – latest updates See all our coronavirus coverage The UK will be asked to reconsider its opposition to waiving intellectual property rights for Covid-19 vaccines and treatments at a… Read More »UK faces calls to drop opposition to patent-free Covid vaccines
Among first 170 Covid cases in trial, eight had received vaccine and 162 were in placebo group Coronavirus – latest updates See all our coronavirus coverage The Pfizer/BioNTech vaccine against Covid-19 performs even better than previously thought, with 95% efficacy, equalling the early results from… Read More »Pfizer Covid-19 vaccine has 95% efficacy and is safe, further analysis shows
Phase 3 success rate of 95% for US firm’s treatment is promising for UK vaccine trial Coronavirus – latest updates See all our coronavirus coverage Hopes are rising for the Covid jab being developed by Oxford University, after Moderna became the second company to reveal… Read More »Moderna vaccine’s effectiveness bodes well for Oxford/AstraZeneca jab
Britain decided not to buy US vaccine and earliest it could be supplied to UK is spring 2021 Coronavirus – latest updates See all our coronavirus coverage The UK has not acquired the Moderna vaccine but is in “advanced discussions” to ensure British access, officials… Read More »UK in ‘advanced discussions’ to buy Moderna Covid vaccine
To make vaccination work, we must reach out to the naturally cautious – a bigger proportion than you might assume Coronavirus – latest updates See all our coronavirus coverage Lydia Guthrie is not very daring by nature. A psychotherapist and mother of two from Oxford,… Read More »It’s the ‘vaccine hesitant’, not anti-vaxxers, who are troubling public health experts | Gaby Hinsliff
Uğur Şahin ‘very confident’ vaccine candidate developed with Pfizer will cause big reduction in cases Coronavirus – latest updates See all our coronavirus coverage The scientist behind the first potential Covid-19 vaccine to clear interim clinical trials says he is “very confident” the jab will… Read More »BioNTech vaccine scientist says jab could halve Covid transmission
Better to build social solidarity than to dismiss reluctance to be immunised as ignorance Coronavirus – latest updates See all our coronavirus coverage “If a strain as deadly as the 1918 influenza emerges and people’s hesitancy to get vaccinated remains at the level it is… Read More »Vaccination hesitancy is about lack of trust. Compulsion is not the answer | Kenan Malik
Exclusive: BioNTech’s CEO Uğur Şahin says he is confident vaccine can ‘bash the virus over the head’ Coronavirus – latest updates See all our coronavirus coverage The scientist behind the first Covid-19 vaccine to clear interim clinical trials says he is confident his product can… Read More »Scientist behind BioNTech/Pfizer vaccine says it can end pandemic
The pharmaceutical industry has long made exorbitant profits by free-riding on research carried out by the public sector Hooray for Pfizer! As news of a vaccine potentially offering 90% protection against Covid-19 offers a life raft for lockdown-weary humanity, perhaps those home-drawn posters on people’s… Read More »The Covid vaccine will benefit humanity – we should all own the patent | Owen Jones
Despite the Pfizer breakthrough, social distancing and remote working won’t disappear overnight Coronavirus – latest updates See all our coronavirus coverage The news this week that the Pfizer/BioNTech vaccine protected more than 90% of recipients is of huge importance. The vaccine efficacy is higher than… Read More »Why a Covid vaccine doesn’t mean the end of face masks yet | David Salisbury
At last, there is hope of an end to this pandemic. Scientists appear to have performed an amazing feat, the rest of us must do our best too Medicine is only partly a matter of science; it is, very much, the business of people. The… Read More »The Guardian view on the Covid vaccine breakthrough: making it work | Editorial
Readers respond to news that an interim analysis has shown Pfizer/BioNTech’s vaccine candidate was 90% effective in protecting people from transmission of the virus in global trials The media have been awash with stories about the apparent success of the Pfizer Covid vaccine following the… Read More »Cautious optimism over Covid-19 vaccine trials | Letters
There are grounds for optimism but also several unknowns around this coronavirus vaccine Coronavirus – latest updates See all our coronavirus coverage Hopes that the end of the coronavirus pandemic has become nearer have soared after the news that a coronavirus vaccine was found to… Read More »6 key questions about the Pfizer/BioNTech Covid-19 vaccine
Interim results show vaccine to be 90% effective, but findings have not been peer-reviewed, Australia has only secured enough for five million people, and there are concerns around its storage temperature • Pfizer says vaccine is 90% effective • What has Pfizer’s vaccine trial found?… Read More »What does the Pfizer Covid vaccine breakthrough mean for Australia?
Interim trial results are encouraging as scientists welcome news Coronavirus – latest updates See all our coronavirus coverage It is not yet the end of the pandemic, but the announcement by Pfizer/BioNTech that their vaccine has been 90% successful in the vital large-scale trials has… Read More »Pfizer/BioNTech vaccine announcement is cause for cautious celebration
Early results from phase 3 trial look promising but there are still many questions to be answered Coronavirus – latest updates See all our coronavirus coverage Pfizer and the German biotech company Biontech said on Monday that they had had encouraging early results from a… Read More »What has Pfizer’s Covid vaccine trial found and is this a breakthrough?
Vaccine being trialled by Oxford University and AstraZeneca offers hope for all age groups Coronavirus – latest updates See all our coronavirus coverage One of the world’s leading Covid-19 experimental vaccines produces an immune response in both older and young adults, raising hopes of a… Read More »Oxford Covid vaccine works in all ages, trials suggest
Shots: Health Canada has approved Luxturna (voretigene neparvovec) as a one-time gene therapy for the treatment of adult & pediatric patients with vision loss due to inherited retinal dystrophy caused by confirmed biallelic RPE65 mutations and who have sufficient viable retinal cells Luxturna is designed… Read More »Novartis’s Luxturna (voretigene neparvovec) Receives Health Canada Approval as the First Gene Replacement Therapy for Inherited Retinal Disease
Pharmaceutical firm reports ‘significant drop in processing capacity’ of reagents, kits and swabs Coronavirus – latest updates See all our coronavirus coverage Concerns have been raised over the supply of vital testing materials for a range of conditions, including Covid-19, following a supply chain problem… Read More »NHS coronavirus tests threatened by Roche supply chain glitch
Dexamethasone ‘normally reserved for people going into respiratory failure’, says expert Trump coronavirus treatment – live updates The latest intervention from Donald Trump’s medical team has been to put the president on dexamethasone, a steroid that is proven, thanks to the UK’s Recovery trial, to… Read More »Trump’s steroid Covid treatment adds to confusion over health
Campaign scoring countries for global access efforts calls for more British transparency Coronavirus – latest updates See all our coronavirus coverage The UK is doing more than most countries to support access to Covid vaccines for the poorest populations in the world, but it is… Read More »UK doing more than most to help poor get Covid vaccine, study finds
Former Sunday Times editor’s genius and empathy will be missed, say campaigners At 5.39am on Thursday morning Guy Tweedy, a thalidomide survivor, campaigner and friend of Harold Evans, received an email from Tina Brown and Georgie and Izzy, the couple’s two children. Related: Sir Harold… Read More »Thalidomide survivors mourn Harold Evans, their hero and friend
Boots, LloydsPharmacy and Well Pharmacy report unprecedented take-up and many chemists run out of stock Coronavirus – latest updates See all our coronavirus coverage Pharmacies across England are struggling to keep up with the demand for the flu vaccine, pausing online bookings and limiting it… Read More »Pharmacies in England pause online flu jab bookings as demand soars
Healthcare workers and health departments will be among the first to use the rapid antigen tests Full Australian Covid stats; Covid restrictions state by state Follow our global live blog Vic cases map; NSW cases map NSW hotspots list; Qld hotspots list Australia’s drugs regulator… Read More »Australia’s drug regulator TGA approves Covid tests that deliver results in 15 minutes
We are raiding the Audio Long Reads archives and bringing you some classic pieces from years past, with new introductions from the authors. This week’s article: Britain’s biggest pharmacy used to be a family business, dedicated to serving society. Now, many of the company’s own… Read More »From the archives: How Boots went rogue – podcast
Regulator agrees to float of UK firms but recreational suppliers still banned Medicinal cannabis companies have been cleared by the UK’s financial regulator to float on the London Stock Exchange but firms that sell marijuana to recreational users will still be banned. The Financial Conduct… Read More »Medical cannabis companies cleared for London stock market
Heidi Chow on why the pharmaceutical industry must not be left in the driving seat to supply an effective Covid-19 vaccine The biggest gamble that governments are taking is not on specific vaccine candidates, but on the pharmaceutical industry itself (The Covid-19 vaccine gamble: where… Read More »Beware of big pharma in rush for Covid-19 vaccine | Letter
Trials of vaccine being developed with AstraZeneca had been paused after participant fell ill Coronavirus – latest updates See all our coronavirus coverage The closely watched trial of an experimental Covid-19 vaccine that was halted after a participant fell ill is to resume in the… Read More »Oxford University resumes Covid-19 vaccine trials
Expert behind vaccine confidence report points to halting of Oxford Covid trial as example Doctors and scientists need to show more empathy towards volunteers in coronavirus vaccine trials who fall ill if the public is to have full confidence in the safety of the vaccines… Read More »Show more empathy to boost confidence in vaccines, scientists told
Pharmaceutical firm’s boss says 2020 deadline possible if regulators move fast Coronavirus – latest updates See all our coronavirus coverage AstraZeneca’s coronavirus vaccine could still be available by the end of the year, or early next year, according to the company’s chief executive, Pascal Soriot,… Read More »Oxford Covid-19 vaccine is still possible this year, says AstraZeneca chief
Tests have been paused after a UK volunteer became ill. How will it affect the search for a cure? The AstraZeneca vaccine trial has been paused – should we be worried? Coronavirus – latest updates See all our coronavirus coverage One of the volunteers in… Read More »Oxford Covid vaccine trial suspension: what happens next?
Is this the end for hopes of an early breakthrough in the race to find a coronavirus drug? The halt in development of the University of Oxford’s Covid-19 vaccine due to a possible adverse reaction in a trial participant has triggered fears of a delay… Read More »The Oxford University AstraZeneca Covid-19 vaccine trial has been paused – should we be worried?
A spokesman for AstraZeneca, the company working on the coronavirus vaccine, said pausing trials was common during vaccine development The development of a promising Covid-19 vaccine has been put on hold due to a possible adverse reaction in a trial participant. A spokesman for AstraZeneca,… Read More »Oxford University Covid vaccine trial put on hold due to possible adverse reaction in participant
World’s largest vaccine makers to begin testing on people in US with eye on rollout in early 2021 Coronavirus – latest updates See all our coronavirus coverage GlaxoSmithKline and Sanofi are to start testing their protein-based Covid-19 vaccine on humans for the first time, following… Read More »GSK and Sanofi to start human trials of potential Covid-19 vaccine
Health care or medical care is very important for health, but it can’t be the only criteria for determining health. In 1948, the WHO defined Health as a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity. The… Read More »Social Detriments of Health Goes Beyond Just Healthcare
While a cure-all drug or therapy is a long way off, there have been some breakthroughs Many different drugs and therapies are being trialled and used on patients with Covid-19. There are some positive results, which may be beginning to bring the hospital death toll… Read More »Six of the most promising treatments for Covid-19 so far
AstraZeneca says it has not discussed ‘emergency use authorisation’ with the US Coronavirus – latest updates See all our coronavirus coverage The company manufacturing the Oxford University coronavirus vaccine has denied it is in talks with the Trump administration about fast-tracking its vaccine for emergency… Read More »Oxford University Covid-19 vaccine firm denies Trump talks
The vaccine is designed to mimic the coronavirus and train the immune system to react if a person is later infected Sign up for Guardian Australia’s coronavirus email Download the free Guardian app to get the most important news notifications The vaccine developed and tested… Read More »Here’s everything you need to know about the potential Oxford University Covid vaccine
Research suggests honey also more effective than many over-the-counter medicines Honey may be better than conventional treatments for coughs, blocked noses and sore throats, researchers have said. The substance is cheap, readily available, and has virtually no side-effects. Doctors can recommend it as a suitable… Read More »Honey better treatment for coughs and colds than antibiotics, study claims
Russia is not the only country pursuing domestic politics over global cooperation in the fight against coronavirus We’re all waiting for a coronavirus vaccine, but when Russia announced earlier this week that it would be the first country to approve one, nobody rejoiced. Scientists pointed… Read More »‘Vaccine nationalism’ stands in the way of an end to the Covid-19 crisis | Stephen Buranyi
Government secures early access to those being developed by Novavax and Janssen Coronavirus – latest updates See all our coronavirus coverage The UK government has reached agreements it says will give British citizens early access to 90m doses of two more potential Covid-19 vaccines. The… Read More »UK agrees deals for 90m doses of two potential coronavirus vaccines
Reasons for shortages are often unclear and substitutes, which are not subsidised by PBS, are prohibitively expensive Australia is experiencing a critical shortage of key drugs including antidepressants, contraceptives and hormone replacement therapies, a situation that experts say highlights systemic problems with medicine supply in… Read More »Australia experiencing critical shortage of antidepressants, contraceptives and HRT
Companies should ensure six weeks’ worth of drugs for end of transition period, DHSC says Pharmaceutical companies should stockpile six weeks’ worth of drugs to guard against disruption at the end of the Brexit transition period, the government has said. The Department of Health and… Read More »UK warns drug firms to stockpile in case of Brexit disruption
Google has reportedly pledged not to use Fitbit’s user data for its advertising business. With the deadline quickly approaching, is it enough that European regulators will approve the deal?
Care homes and members of public told to immediately stop using firm’s kits Coronavirus – latest updates See all our coronavirus coverage The UK government has instructed care homes and members of the public to immediately stop using coronavirus testing kits produced by a healthcare… Read More »UK government orders halt to Randox Covid-19 tests over safety issues
An official review of vaginal mesh and medicines in pregnancy reveals systemic weaknesses, and sexism too Greater openness about women’s bodies was one of the big themes of postwar feminism. Access to contraception and the right to terminate a pregnancy were crucial stepping stones on… Read More »The Guardian view on a women’s health scandal: under the skin | Editorial
Cumberlege report is a damning reminder of how arrogant, intimidating doctors have suppressed their patients’ views Julia Cumberlege’s report into avoidable harm inflicted by the healthcare system exposes an institutional inability to listen to patients in general and women in particular. Her investigation into decades… Read More »Pelvic mesh scandal is what happens when men with power ignore women | Richard Vize
We need a public register to show if healthcare professionals are in the pay of industry – or more patients will suffer It was never “just women’s problems”. After decades of having their suffering dismissed, many patients will have been relieved about the publication of… Read More »The pelvic mesh scandal makes it clear: doctors must declare any funding | Margaret McCartney
With the NHS deal on Kaftrio, I’m likely to live longer. This is why swift access to novel treatments is so important It’s been 15 weeks since I went into isolation to shield from Covid-19 – having cystic fibrosis (CF) put me in the high-risk… Read More »
Hydroxychloroquine and lopinavir/ritonavir not found to help patients in hospital Coronavirus – latest updates See all our coronavirus coverage The World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir for patients… Read More »
No other country will be able to buy remdesivir, which can help recovery from Covid-19, for next three months at least Coronavirus – latest US updates Coronavirus – latest updates See all our coronavirus coverage The US has bought up virtually all the stocks for… Read More »US secures world stock of key Covid-19 drug remdesivir
I have to inject myself with needles just to stay alive. Still, Bayer will continue to sell Roundup, and refused to label it as carcinogenic Last Wednesday was my 71st birthday, a low-key celebration in these Covid-19 times. Then I heard the news that the… Read More »I believe Roundup gave me cancer. The Monsanto settlement is a slap in the face | Christine Sheppard
Evidence given to parliamentary committee sparks new calls to develop national capability to manufacture medicines and key supplies Australian companies were “shocked” to experience price-gouging and had trouble accessing critical supplies to make medicines and personal protective equipment at the height of the pandemic, a… Read More »Australian drugmakers hit by critical shortages at height of pandemic, inquiry hears
Rich countries’ governments are putting all their trust in a marriage of markets and philanthropy called Gavi Vaccines for Covid-19 are coming. Billions of dollars are flowing in, over 100 efforts are under way, and at least 13 leading candidates are already being tested on… Read More »
Thanks to the success of the Human Genome Project, 20 years ago this week, scientists can track biology and disease at a molecular level Twenty years ago this week, an international group of scientists announced it had put together the first genetic blueprint of a… Read More »‘The wondrous map’: how unlocking human DNA changed the course of science
Manufacturers warn they will struggle to meet demand as governments seek to ease pressure on health services Coronavirus – latest updates See all our coronavirus coverage Fears of a second wave of coronavirus have sparked a global scramble for influenza shots from countries that hope… Read More »Demand for flu vaccine soars as countries plan for second Covid-19 wave
Richard Horton does not hold back in his criticism of the UK’s response to the pandemic and the medical establishment’s part in backing fatal government decisions Coronavirus – latest updates See all our coronavirus coverage There is a school of thought that says now is… Read More »
TEDMED Meetups, uniquely designed conversations, engage the entire TEDMED community to share their individual perspectives and voices to help improve humanity’s health. Read on to view some of the details of these captivating conversations taking place at TEDMED 2020. Meetup 1 Tuesday, March 3rd, 8:00… Read More »TEDMED 2020 Meetups
Struggling to sell one multi-million dollar home currently on the market won’t stop actress and singer Jennifer Lopez from expanding her property collection. Lopez has reportedly added to her real estate holdings an eight-plus acre estate in Bel-Air anchored by a multi-level mansion. The property,… Read More »These insects carry enough bacteria to the cause
Struggling to sell one multi-million dollar home currently on the market won’t stop actress and singer Jennifer Lopez from expanding her property collection. Lopez has reportedly added to her real estate holdings an eight-plus acre estate in Bel-Air anchored by a multi-level mansion. The property,… Read More »Morning people may have the lower breast cancer risk
Struggling to sell one multi-million dollar home currently on the market won’t stop actress and singer Jennifer Lopez from expanding her property collection. Lopez has reportedly added to her real estate holdings an eight-plus acre estate in Bel-Air anchored by a multi-level mansion. The property,… Read More »She bought the Home the full same year she married
Struggling to sell one multi-million dollar home currently on the market won’t stop actress and singer Jennifer Lopez from expanding her property collection. Lopez has reportedly added to her real estate holdings an eight-plus acre estate in Bel-Air anchored by a multi-level mansion. The property,… Read More »How childhood viral infections may later drive multiple
Serves 3 Ingredients: 270 g (6 cups) frozen baby spinach leaves 3 frozen bananas 945 g (3 cups) frozen mango pieces 750 ml (3 cups) unsweetened vanilla almond milk, plus 250 ml (1 cup) unsweetened vanilla almond milk extra Place the spinach,… Read More »Green Supreme Layered Smoothie
What is wellbeing? I would describe wellbeing as the holistic experience of feeling energised, comfortable, connected and inspired. Our personal wellbeing is cultivated by all the unconditionally kind, wise and compassionate choices we make to nurture our health and happiness. These choices encompass our thoughts… Read More »10 tips for cultivating wellbeing
Vitamin E The topical application of vitamin E has been used clinically to treat sunburn and scar tissue and is commonly used to assist in wound healing of abrasions, burns and stretch marks. Pierce a capsule containing pure vitamin E and use the oil directly… Read More »Natural remedies to soothe sun-damaged skin
Embarking on a journey of self-discovery and growth begins with an intense period of introspection. It was a crisp autumn night when I pulled up outside a niche art gallery in the heart of Collingwood in Melbourne. I sat in my car for a few… Read More »The path of self-discovery using psychotherapy requires intense introspection